119 results
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
ACAM2000 BLA on file with the FDA. Vaccine Fill and Finish The Contractor shall maintain a validated filling, lyophilization, labeling and packaging … and associated process development. Requirements for Packaging & Delivery The products shall be delivered as follows: ACAM2000, (Smallpox (Vaccinia) Vaccine, Live
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
9 Jan 24
Regulation FD Disclosure
8:40am
Bioservices Business
13 Contract Development & Manufacturing (CDMO) offerings: Development services Drug substance Drug product & packaging Mammalian
424B5
ncqo1
18 May 23
Prospectus supplement for primary offering
7:45am
8-K
EX-10.2
g40s st3z7g9
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
8-K
EX-99.1
x8mrzd4i9ha
29 Mar 23
Regulation FD Disclosure
9:29am
8-K
EX-2
4igf6fcg
18 May 22
Entry into a Material Definitive Agreement
5:13pm
8-K
EX-99.1
j00wqz
14 Jan 22
Departure of Directors or Certain Officers
6:37am
CORRESP
f675b220qho9
30 Sep 21
Correspondence with SEC
12:00am
8-K/A
EX-10.1
3oadh98xr0yfx1z
9 Sep 21
Financial Statements and Exhibits
4:33pm